Skip to main content
Erschienen in: Acta Neuropathologica 5/2005

01.11.2005 | Regular Paper

Extensive cortico-subcortical lesions in Wilson’s disease: clinico-pathological study of two cases

verfasst von: Jacqueline Mikol, Claude Vital, Michel Wassef, Philippe Chappuis, Joël Poupon, Monique Lecharpentier, France Woimant

Erschienen in: Acta Neuropathologica | Ausgabe 5/2005

Einloggen, um Zugang zu erhalten

Abstract

Wilson’s disease (WD) with extensive cortico-subcortical lesions represents a rare neuropathological subgroup, the pathogenesis of which is not clearly determined. We report two new cases with identical lesions. In the families of each of the patient, there were mutations in the ATPase7B gene, especially in the family of proband 1, and in the first cousin of proband 2. These cases included massive destruction of the white matter in superior gyri, mostly frontal, extending to the deep cortex with neuronal loss and capillary proliferation. Astrocytes were of Alzheimer type 1 and 2; and type 1 were labeled by anti-metallothionein. Opalski cells were abundant and their macrophagic lineage was confirmed by immunostaining. Among the possible mechanisms proposed, the role of vascular factors and penicillamine treatment could be excluded. Cerebral copper content in white matter and putamen of case 1 was at the same level as in common WD but accumulation of unbound copper in the white matter was a distinctive feature, which suggested a pathological neurotoxic effect.
Literatur
1.
Zurück zum Zitat Aisen AM, Martel W, Gabrielsen TO, Glazer GM, Brewer G, Young AB, Hill G (1985) Wilson disease of the brain: MR imaging. Radiology 157:137–141PubMed Aisen AM, Martel W, Gabrielsen TO, Glazer GM, Brewer G, Young AB, Hill G (1985) Wilson disease of the brain: MR imaging. Radiology 157:137–141PubMed
2.
Zurück zum Zitat Alajouanine T, Bertrand I, Boudin G, Pepin B (1955) Etude anatomo-clinique, biologique et chimique d’un cas de pseudo-sclérose de Westphal-Strumpell. Rev Neurol (Paris) 93:701–729 Alajouanine T, Bertrand I, Boudin G, Pepin B (1955) Etude anatomo-clinique, biologique et chimique d’un cas de pseudo-sclérose de Westphal-Strumpell. Rev Neurol (Paris) 93:701–729
3.
Zurück zum Zitat Anton G 1908 cited by Finlayson and Superville Anton G 1908 cited by Finlayson and Superville
4.
Zurück zum Zitat Anzil AP, Herrlinger H, Blinzinger K, Heldrich A (1974) Ultrastructure of brain and nerve biopsy tissue in Wilson disease. Arch Neurol 31:94–100PubMed Anzil AP, Herrlinger H, Blinzinger K, Heldrich A (1974) Ultrastructure of brain and nerve biopsy tissue in Wilson disease. Arch Neurol 31:94–100PubMed
5.
Zurück zum Zitat Brewer GJ, Terry CA, Aisen AM, Hill GM (1987) Worsening of neurologic syndrome in patients with Wilson’s disease with initial penicillamine therapy. Arch Neurol 44:490–493PubMed Brewer GJ, Terry CA, Aisen AM, Hill GM (1987) Worsening of neurologic syndrome in patients with Wilson’s disease with initial penicillamine therapy. Arch Neurol 44:490–493PubMed
6.
Zurück zum Zitat Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW (1993) The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 5:327–337CrossRefPubMed Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW (1993) The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 5:327–337CrossRefPubMed
7.
Zurück zum Zitat Bush VJ, Moyer TP, Batts KP, Parisi JE (1995) Essential and toxic element concentrations in fresh and formalin-fixed human autopsy tissues. Clin Chem 41:284–294PubMed Bush VJ, Moyer TP, Batts KP, Parisi JE (1995) Essential and toxic element concentrations in fresh and formalin-fixed human autopsy tissues. Clin Chem 41:284–294PubMed
8.
Zurück zum Zitat Butterworth RF (1992) Pathogenesis and treatment of portal-systemic encephalopathy: an update. Dig Dis Sci 37:321–327CrossRefPubMed Butterworth RF (1992) Pathogenesis and treatment of portal-systemic encephalopathy: an update. Dig Dis Sci 37:321–327CrossRefPubMed
9.
Zurück zum Zitat Butterworth RF (2002) Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab Brain Dis 17:221–227CrossRefPubMed Butterworth RF (2002) Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab Brain Dis 17:221–227CrossRefPubMed
10.
Zurück zum Zitat Cavanagh JB, Harding BN (1994) Pathogenic factors underlying the lesions in Leigh’s disease. Tissue responses to cellular energy deprivation and their clinico-pathological consequences. Brain 117:1357–1376PubMed Cavanagh JB, Harding BN (1994) Pathogenic factors underlying the lesions in Leigh’s disease. Tissue responses to cellular energy deprivation and their clinico-pathological consequences. Brain 117:1357–1376PubMed
11.
Zurück zum Zitat Chu NS (1989) Clinical, CT and evoked potential manifestations in Wilson’s disease with cerebral white matter involvement. Clin Neurol Neurosurg 91:45–51PubMed Chu NS (1989) Clinical, CT and evoked potential manifestations in Wilson’s disease with cerebral white matter involvement. Clin Neurol Neurosurg 91:45–51PubMed
12.
Zurück zum Zitat Cumings JN (1949) The copper and iron content of brain and liver in the normal and in hepato-lenticular degeneration. Brain 71:410–415 Cumings JN (1949) The copper and iron content of brain and liver in the normal and in hepato-lenticular degeneration. Brain 71:410–415
13.
Zurück zum Zitat Duc HH, Hefter H, Stremmel W, Castaneda-Guillot C, Hernandez Hernandez A, Cox DW, Auburger G (1998) His1069Gln and six novel Wilson disease mutations: analysis of relevance for early diagnosis and phenotype. Eur J Hum Genet 6:616–623PubMed Duc HH, Hefter H, Stremmel W, Castaneda-Guillot C, Hernandez Hernandez A, Cox DW, Auburger G (1998) His1069Gln and six novel Wilson disease mutations: analysis of relevance for early diagnosis and phenotype. Eur J Hum Genet 6:616–623PubMed
14.
Zurück zum Zitat Ferenci P (1999) Wilson’s disease. Ital J Gastroenterol Hepatol 31:416–425PubMed Ferenci P (1999) Wilson’s disease. Ital J Gastroenterol Hepatol 31:416–425PubMed
15.
Zurück zum Zitat Finlayson MH, Superville B (1981) Distribution of cerebral lesions in acquired hepatocerebral degeneration. Brain 104:79–95PubMed Finlayson MH, Superville B (1981) Distribution of cerebral lesions in acquired hepatocerebral degeneration. Brain 104:79–95PubMed
16.
Zurück zum Zitat Gitlin JD (2003) Wilson disease. Gastroenterology 125:1868–1877PubMed Gitlin JD (2003) Wilson disease. Gastroenterology 125:1868–1877PubMed
17.
Zurück zum Zitat Gu M, Cooper JM, Butler P, Walker AP, Mistry PK, Dooley JS, Schapira AH (2000) Oxidative-phosphorylation defects in liver of patients with Wilson’s disease. Lancet 356:469–474CrossRefPubMed Gu M, Cooper JM, Butler P, Walker AP, Mistry PK, Dooley JS, Schapira AH (2000) Oxidative-phosphorylation defects in liver of patients with Wilson’s disease. Lancet 356:469–474CrossRefPubMed
18.
Zurück zum Zitat Hall H (1921) La dégénérescence hépato-lenticulaire: maladie de Wilson—pseudo-sclérose. Masson, Paris Hall H (1921) La dégénérescence hépato-lenticulaire: maladie de Wilson—pseudo-sclérose. Masson, Paris
19.
Zurück zum Zitat Hermann W, Caca K, Eggers B, Villmann T, Clark D, Berr F, Wagner A (2002) Genotype correlation with fine motor symptoms in patients with Wilson’s disease. Eur Neurol 48:97–101CrossRefPubMed Hermann W, Caca K, Eggers B, Villmann T, Clark D, Berr F, Wagner A (2002) Genotype correlation with fine motor symptoms in patients with Wilson’s disease. Eur Neurol 48:97–101CrossRefPubMed
20.
Zurück zum Zitat Homen EA 1892 cited by Finlayson and Superville Homen EA 1892 cited by Finlayson and Superville
21.
Zurück zum Zitat Horoupian DS, Sternlieb I, Scheinberg IH (1988) Neuropathological findings in penicillamine-treated patients with Wilson’s disease. Clin Neuropathol 7:62–67PubMed Horoupian DS, Sternlieb I, Scheinberg IH (1988) Neuropathological findings in penicillamine-treated patients with Wilson’s disease. Clin Neuropathol 7:62–67PubMed
22.
Zurück zum Zitat Huang CC, Chu NS (1992) Resolution of cerebral white matter lesions following long-term penicillamine therapy for Wilson’s disease: report of a case. J Formos Med Assoc 91:627–629PubMed Huang CC, Chu NS (1992) Resolution of cerebral white matter lesions following long-term penicillamine therapy for Wilson’s disease: report of a case. J Formos Med Assoc 91:627–629PubMed
23.
Zurück zum Zitat Ishino H, Mii T, Hayashi Y, Saito A, Otsuki S (1972) A case of Wilson’s disease with enormous cavity formation of cerebral white matter. Neurology 22:905–909PubMed Ishino H, Mii T, Hayashi Y, Saito A, Otsuki S (1972) A case of Wilson’s disease with enormous cavity formation of cerebral white matter. Neurology 22:905–909PubMed
24.
Zurück zum Zitat Konowalow N (1941) Histopathologie der hepato-lentikulären Degeneration. Z Ges Neurol Psychiatr 171:200–228 Konowalow N (1941) Histopathologie der hepato-lentikulären Degeneration. Z Ges Neurol Psychiatr 171:200–228
25.
Zurück zum Zitat Lawler GA, Pennock JM, Steiner RE, Jenkins WJ, Sherlock S, Young IR (1983) Nuclear magnetic resonance (NMR) imaging in Wilson disease. J Comput Assist Tomogr 7:1–8PubMed Lawler GA, Pennock JM, Steiner RE, Jenkins WJ, Sherlock S, Young IR (1983) Nuclear magnetic resonance (NMR) imaging in Wilson disease. J Comput Assist Tomogr 7:1–8PubMed
26.
Zurück zum Zitat Leigh D (1951) Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry 14:216–221PubMed Leigh D (1951) Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatry 14:216–221PubMed
27.
Zurück zum Zitat Loudianos G, Dessi V, Lovicu M, Angius A, Nurchi A, Sturniolo GC, Marcellini M, Zancan L, Bragetti P, Akar N, Yagci R, Vegnente A, Cao A, Pirastu M (1998) Further delineation of the molecular pathology of Wilson disease in the Mediterranean population. Hum Mutat 12:89–94CrossRefPubMed Loudianos G, Dessi V, Lovicu M, Angius A, Nurchi A, Sturniolo GC, Marcellini M, Zancan L, Bragetti P, Akar N, Yagci R, Vegnente A, Cao A, Pirastu M (1998) Further delineation of the molecular pathology of Wilson disease in the Mediterranean population. Hum Mutat 12:89–94CrossRefPubMed
28.
Zurück zum Zitat Maier-Dobersberger T, Ferenci P, Polli C, Balac P, Dienes HP, Kaserer K, Datz C, Vogel W, Gangl A (1997) Detection of the His1069Gln mutation in Wilson disease by rapid polymerase chain reaction. Ann Intern Med 127:21–26PubMed Maier-Dobersberger T, Ferenci P, Polli C, Balac P, Dienes HP, Kaserer K, Datz C, Vogel W, Gangl A (1997) Detection of the His1069Gln mutation in Wilson disease by rapid polymerase chain reaction. Ann Intern Med 127:21–26PubMed
29.
Zurück zum Zitat Nayrac P, Graux P, Van Bogaert L, Rabache R (1957) Etude biochimique et histologique sur une fratrie wilsonienne d’une stricte homotypie anatomoclinique. Rev Neurol (Paris) 96:196–215 Nayrac P, Graux P, Van Bogaert L, Rabache R (1957) Etude biochimique et histologique sur une fratrie wilsonienne d’une stricte homotypie anatomoclinique. Rev Neurol (Paris) 96:196–215
30.
Zurück zum Zitat Richter R (1948) The pallial component in hepato-lenticular degeneration. J Neuropathol Exp Neurol 7:1–18 Richter R (1948) The pallial component in hepato-lenticular degeneration. J Neuropathol Exp Neurol 7:1–18
31.
Zurück zum Zitat Schulman S (1968) Wilson’s disease. In: Minckler J (ed) Pathology of the nervous system, vol 1. McGraw-Hill, New York, pp 1139–1162 Schulman S (1968) Wilson’s disease. In: Minckler J (ed) Pathology of the nervous system, vol 1. McGraw-Hill, New York, pp 1139–1162
32.
Zurück zum Zitat Schulman S, Barbeau A (1963) Wilson’s disease: a case with almost total loss of white matter. J Neuropathol Exp Neurol 22:105–119PubMed Schulman S, Barbeau A (1963) Wilson’s disease: a case with almost total loss of white matter. J Neuropathol Exp Neurol 22:105–119PubMed
33.
Zurück zum Zitat Shah AB, Chernov I, Zhang HT, Ross BM, Das K, Lutsenko S, Parano E, Pavone L, Evgrafov O, Ivanova-Smolenskaya IA, Anneren G, Westermark K, Urrutia FH, Penchaszadeh GK, Sternlieb I, Scheinberg IH, Gilliam TC, Petrukhin K (1997) Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses. Am J Hum Genet 61:317–328PubMed Shah AB, Chernov I, Zhang HT, Ross BM, Das K, Lutsenko S, Parano E, Pavone L, Evgrafov O, Ivanova-Smolenskaya IA, Anneren G, Westermark K, Urrutia FH, Penchaszadeh GK, Sternlieb I, Scheinberg IH, Gilliam TC, Petrukhin K (1997) Identification and analysis of mutations in the Wilson disease gene (ATP7B): population frequencies, genotype-phenotype correlation, and functional analyses. Am J Hum Genet 61:317–328PubMed
34.
Zurück zum Zitat Sheline CT, Choi EH, Kim-Han JS, Dugan LL, Choi DW (2002) Cofactors of mitochondrial enzymes attenuate copper-induced death in vitro and in vivo. Ann Neurol 52:195–204CrossRefPubMed Sheline CT, Choi EH, Kim-Han JS, Dugan LL, Choi DW (2002) Cofactors of mitochondrial enzymes attenuate copper-induced death in vitro and in vivo. Ann Neurol 52:195–204CrossRefPubMed
35.
Zurück zum Zitat Shimoji A, Miyakawa T, Watanabe K, Yamashita K, Katsuragi S, Kabashima K (1987) Wilson’s disease with extensive degeneration of cerebral white matter and cortex. Jpn J Psychiatry Neurol 41:709–717PubMed Shimoji A, Miyakawa T, Watanabe K, Yamashita K, Katsuragi S, Kabashima K (1987) Wilson’s disease with extensive degeneration of cerebral white matter and cortex. Jpn J Psychiatry Neurol 41:709–717PubMed
36.
Zurück zum Zitat Sparaco M, Bonilla E, DiMauro S, Powers JM (1993) Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects. J Neuropathol Exp Neurol 52:1–10PubMed Sparaco M, Bonilla E, DiMauro S, Powers JM (1993) Neuropathology of mitochondrial encephalomyopathies due to mitochondrial DNA defects. J Neuropathol Exp Neurol 52:1–10PubMed
37.
Zurück zum Zitat Spielmeyer W (1920) Die histopathologische Zusammenhörigkeit der Wilsonschen Krankheit. Z Ges Neurol Psychiatr 57:312–351 Spielmeyer W (1920) Die histopathologische Zusammenhörigkeit der Wilsonschen Krankheit. Z Ges Neurol Psychiatr 57:312–351
38.
Zurück zum Zitat Starosta-Rubinstein S, Young AB, Kluin K, Hill G, Aisen AM, Gabrielsen T, Brewer GJ (1987) Clinical assessment of 31 patients with Wilson’s disease. Correlations with structural changes on magnetic resonance imaging. Arch Neurol 44:365–370PubMed Starosta-Rubinstein S, Young AB, Kluin K, Hill G, Aisen AM, Gabrielsen T, Brewer GJ (1987) Clinical assessment of 31 patients with Wilson’s disease. Correlations with structural changes on magnetic resonance imaging. Arch Neurol 44:365–370PubMed
39.
Zurück zum Zitat Tanzi RE, Petrukhin K, Chernov I, Pellequer JL, Wasco W, Ross B, Romano DM, Parano E, Pavone L, Brzustowicz LM (1993) The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 5:344–350CrossRefPubMed Tanzi RE, Petrukhin K, Chernov I, Pellequer JL, Wasco W, Ross B, Romano DM, Parano E, Pavone L, Brzustowicz LM (1993) The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 5:344–350CrossRefPubMed
40.
Zurück zum Zitat Thomas GR, Roberts EA, Walshe JM, Cox DW (1995) Haplotypes and mutations in Wilson disease. Am J Hum Genet 56:1315–1319PubMed Thomas GR, Roberts EA, Walshe JM, Cox DW (1995) Haplotypes and mutations in Wilson disease. Am J Hum Genet 56:1315–1319PubMed
41.
Zurück zum Zitat Walker JM, Tsivkovskii R, Lutsenko S (2002) Metallochaperone Atox1 transfers copper to the NH2-terminal domain of the Wilson’s disease protein and regulates its catalytic activity. J Biol Chem 277:27953–27959CrossRefPubMed Walker JM, Tsivkovskii R, Lutsenko S (2002) Metallochaperone Atox1 transfers copper to the NH2-terminal domain of the Wilson’s disease protein and regulates its catalytic activity. J Biol Chem 277:27953–27959CrossRefPubMed
42.
Zurück zum Zitat Wang XF, Cynader MS (2001) Pyruvate released by astrocytes protects neurons from copper-catalyzed cysteine neurotoxicity. J Neurosci 21:3322–3331PubMed Wang XF, Cynader MS (2001) Pyruvate released by astrocytes protects neurons from copper-catalyzed cysteine neurotoxicity. J Neurosci 21:3322–3331PubMed
43.
Zurück zum Zitat White AR, Multhaup G, Maher F, Bellingham S, Camakaris J, Zheng H, Bush AI, Beyreuther K, Masters CL, Cappai R (1999) The Alzheimer’s disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal cultures. J Neurosci 19:9170–9179PubMed White AR, Multhaup G, Maher F, Bellingham S, Camakaris J, Zheng H, Bush AI, Beyreuther K, Masters CL, Cappai R (1999) The Alzheimer’s disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal cultures. J Neurosci 19:9170–9179PubMed
44.
Zurück zum Zitat Wilson S (1912) Progressive lenticular degeneration:a familial nervous disease associated with cirrhosis of the liver. Brain 34:295–507 Wilson S (1912) Progressive lenticular degeneration:a familial nervous disease associated with cirrhosis of the liver. Brain 34:295–507
45.
Zurück zum Zitat Yoshii F, Takahashi W, Shinohara Y (1996) A Wilson’s disease patient with prominent cerebral white matter lesions: five-year follow-up by MRI. Eur Neurol 36:392–393PubMed Yoshii F, Takahashi W, Shinohara Y (1996) A Wilson’s disease patient with prominent cerebral white matter lesions: five-year follow-up by MRI. Eur Neurol 36:392–393PubMed
Metadaten
Titel
Extensive cortico-subcortical lesions in Wilson’s disease: clinico-pathological study of two cases
verfasst von
Jacqueline Mikol
Claude Vital
Michel Wassef
Philippe Chappuis
Joël Poupon
Monique Lecharpentier
France Woimant
Publikationsdatum
01.11.2005
Verlag
Springer-Verlag
Erschienen in
Acta Neuropathologica / Ausgabe 5/2005
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-005-1061-1

Weitere Artikel der Ausgabe 5/2005

Acta Neuropathologica 5/2005 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Thrombektomie auch bei großen Infarkten von Vorteil

16.05.2024 Ischämischer Schlaganfall Nachrichten

Auch ein sehr ausgedehnter ischämischer Schlaganfall scheint an sich kein Grund zu sein, von einer mechanischen Thrombektomie abzusehen. Dafür spricht die LASTE-Studie, an der Patienten und Patientinnen mit einem ASPECTS von maximal 5 beteiligt waren.

Schwindelursache: Massagepistole lässt Otholiten tanzen

14.05.2024 Benigner Lagerungsschwindel Nachrichten

Wenn jüngere Menschen über ständig rezidivierenden Lagerungsschwindel klagen, könnte eine Massagepistole der Auslöser sein. In JAMA Otolaryngology warnt ein Team vor der Anwendung hochpotenter Geräte im Bereich des Nackens.

Schützt Olivenöl vor dem Tod durch Demenz?

10.05.2024 Morbus Alzheimer Nachrichten

Konsumieren Menschen täglich 7 Gramm Olivenöl, ist ihr Risiko, an einer Demenz zu sterben, um mehr als ein Viertel reduziert – und dies weitgehend unabhängig von ihrer sonstigen Ernährung. Dafür sprechen Auswertungen zweier großer US-Studien.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.